Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review
O objetivo do estudo foi revisar a literatura sobre a prevalência da síndrome metabólica e seus componentes em adolescentes (10-19 anos). Realizou-se busca nas bases eletrônicas MEDLINE e SciELO, referências dos artigos encontrados e contato com autores. Apenas artigos originais que utilizaram os cr...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Augusto César Ferreira de Moraes [verfasserIn] Camila Sanchez Fulaz [verfasserIn] Edna Regina Netto-Oliveira [verfasserIn] Felipe Fossati Reichert [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch ; Spanisch ; Portugiesisch |
| Erschienen: |
2009 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Cadernos de Saúde Pública - Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2004, 25(2009), 6, Seite 1195-1202 |
|---|---|
| Übergeordnetes Werk: |
volume:25 ; year:2009 ; number:6 ; pages:1195-1202 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.1590/S0102-311X2009000600002 |
|---|
| Katalog-ID: |
DOAJ041496159 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ041496159 | ||
| 003 | DE-627 | ||
| 005 | 20230308050535.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2009 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1590/S0102-311X2009000600002 |2 doi | |
| 035 | |a (DE-627)DOAJ041496159 | ||
| 035 | |a (DE-599)DOAJa1991fab92d74b62a64677393da45d7c | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a spa |a por | ||
| 050 | 0 | |a RA1-1270 | |
| 100 | 0 | |a Augusto César Ferreira de Moraes |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review |
| 264 | 1 | |c 2009 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a O objetivo do estudo foi revisar a literatura sobre a prevalência da síndrome metabólica e seus componentes em adolescentes (10-19 anos). Realizou-se busca nas bases eletrônicas MEDLINE e SciELO, referências dos artigos encontrados e contato com autores. Apenas artigos originais que utilizaram os critérios da Organização Mundial da Saúde (OMS) ou do National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) foram considerados. Dezesseis estudos preencheram os critérios de inclusão. Destes, oito estudos foram realizados em países de renda baixa ou média, mas nenhum no Brasil. A prevalência de síndrome metabólica entre os estudos que utilizaram o critério da NCEP-ATP III variou de 4,2% a 15,4%. Utilizando-se o critério da OMS, as prevalências foram mais elevadas: 4,5% a 38,7%. Dentre os componentes da síndrome, o triglicéride elevado apresentou maior prevalência, com valores entre 4,9% a 75%, e a glicose elevada apresentou as menores prevalências. Conclui-se que, apesar do baixo número de estudos localizados, a ocorrência da síndrome metabólica entre adolescentes é um problema de saúde com alta prevalência. A prevalência de síndrome metabólica em adolescentes brasileiros é desconhecida.<br<The present study aimed to review the literature on the prevalence of metabolic syndrome and its components in adolescents (10-19 years old). The search was conducted in online databases (MEDLINE and SciELO), references from retrieved articles, and contacts with authors. Only original articles using either the criteria of the World Health Organization (WHO) or the National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP-III) were considered. Sixteen studies met the inclusion criteria. Eight studies were undertaken in low to medium-income countries, but none of them in Brazil. Prevalence of metabolic syndrome in studies using the NCEP-ATP III criteria ranged from 4.2% to 15.4%. Prevalence in studies using the WHO criteria was slightly higher: 4.5% to 38.7%. High triglyceride level was the most frequent component of the metabolic syndrome, with prevalence ranging from 4.9% to 75.0%, while high blood glucose showed the lowest prevalence. In conclusion, although there are few available studies, metabolic syndrome in adolescents is a highly prevalent health issue. The exact prevalence of metabolic syndrome in Brazilian adolescents is unknown. | ||
| 650 | 4 | |a Adolescente | |
| 650 | 4 | |a Síndrome Metabólica X | |
| 650 | 4 | |a Obesidade | |
| 650 | 4 | |a Adolescent | |
| 650 | 4 | |a Metabolic X Syndrome | |
| 650 | 4 | |a Obesity | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 653 | 0 | |a Public aspects of medicine | |
| 700 | 0 | |a Camila Sanchez Fulaz |e verfasserin |4 aut | |
| 700 | 0 | |a Edna Regina Netto-Oliveira |e verfasserin |4 aut | |
| 700 | 0 | |a Felipe Fossati Reichert |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Cadernos de Saúde Pública |d Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2004 |g 25(2009), 6, Seite 1195-1202 |w (DE-627)324484798 |w (DE-600)2027139-6 |x 16784464 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2009 |g number:6 |g pages:1195-1202 |
| 856 | 4 | 0 | |u https://doi.org/10.1590/S0102-311X2009000600002 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/a1991fab92d74b62a64677393da45d7c |z kostenfrei |
| 856 | 4 | 0 | |u http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2009000600002 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0102-311X |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1678-4464 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_39 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_95 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_151 | ||
| 912 | |a GBV_ILN_161 | ||
| 912 | |a GBV_ILN_170 | ||
| 912 | |a GBV_ILN_206 | ||
| 912 | |a GBV_ILN_213 | ||
| 912 | |a GBV_ILN_230 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_602 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4037 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4249 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_4322 | ||
| 912 | |a GBV_ILN_4323 | ||
| 912 | |a GBV_ILN_4324 | ||
| 912 | |a GBV_ILN_4325 | ||
| 912 | |a GBV_ILN_4338 | ||
| 912 | |a GBV_ILN_4367 | ||
| 912 | |a GBV_ILN_4700 | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2009 |e 6 |h 1195-1202 | ||
| author_variant |
a c f d m acfdm c s f csf e r n o erno f f r ffr |
|---|---|
| matchkey_str |
article:16784464:2009----::rvlcaenrmmtbiamdlsetsmrvsssetcpeaecomtblcydoe |
| hierarchy_sort_str |
2009 |
| callnumber-subject-code |
RA |
| publishDate |
2009 |
| allfields |
10.1590/S0102-311X2009000600002 doi (DE-627)DOAJ041496159 (DE-599)DOAJa1991fab92d74b62a64677393da45d7c DE-627 ger DE-627 rakwb eng spa por RA1-1270 Augusto César Ferreira de Moraes verfasserin aut Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review 2009 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier O objetivo do estudo foi revisar a literatura sobre a prevalência da síndrome metabólica e seus componentes em adolescentes (10-19 anos). Realizou-se busca nas bases eletrônicas MEDLINE e SciELO, referências dos artigos encontrados e contato com autores. Apenas artigos originais que utilizaram os critérios da Organização Mundial da Saúde (OMS) ou do National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) foram considerados. Dezesseis estudos preencheram os critérios de inclusão. Destes, oito estudos foram realizados em países de renda baixa ou média, mas nenhum no Brasil. A prevalência de síndrome metabólica entre os estudos que utilizaram o critério da NCEP-ATP III variou de 4,2% a 15,4%. Utilizando-se o critério da OMS, as prevalências foram mais elevadas: 4,5% a 38,7%. Dentre os componentes da síndrome, o triglicéride elevado apresentou maior prevalência, com valores entre 4,9% a 75%, e a glicose elevada apresentou as menores prevalências. Conclui-se que, apesar do baixo número de estudos localizados, a ocorrência da síndrome metabólica entre adolescentes é um problema de saúde com alta prevalência. A prevalência de síndrome metabólica em adolescentes brasileiros é desconhecida.<br<The present study aimed to review the literature on the prevalence of metabolic syndrome and its components in adolescents (10-19 years old). The search was conducted in online databases (MEDLINE and SciELO), references from retrieved articles, and contacts with authors. Only original articles using either the criteria of the World Health Organization (WHO) or the National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP-III) were considered. Sixteen studies met the inclusion criteria. Eight studies were undertaken in low to medium-income countries, but none of them in Brazil. Prevalence of metabolic syndrome in studies using the NCEP-ATP III criteria ranged from 4.2% to 15.4%. Prevalence in studies using the WHO criteria was slightly higher: 4.5% to 38.7%. High triglyceride level was the most frequent component of the metabolic syndrome, with prevalence ranging from 4.9% to 75.0%, while high blood glucose showed the lowest prevalence. In conclusion, although there are few available studies, metabolic syndrome in adolescents is a highly prevalent health issue. The exact prevalence of metabolic syndrome in Brazilian adolescents is unknown. Adolescente Síndrome Metabólica X Obesidade Adolescent Metabolic X Syndrome Obesity Medicine R Public aspects of medicine Camila Sanchez Fulaz verfasserin aut Edna Regina Netto-Oliveira verfasserin aut Felipe Fossati Reichert verfasserin aut In Cadernos de Saúde Pública Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2004 25(2009), 6, Seite 1195-1202 (DE-627)324484798 (DE-600)2027139-6 16784464 nnns volume:25 year:2009 number:6 pages:1195-1202 https://doi.org/10.1590/S0102-311X2009000600002 kostenfrei https://doaj.org/article/a1991fab92d74b62a64677393da45d7c kostenfrei http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2009000600002 kostenfrei https://doaj.org/toc/0102-311X Journal toc kostenfrei https://doaj.org/toc/1678-4464 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2009 6 1195-1202 |
| spelling |
10.1590/S0102-311X2009000600002 doi (DE-627)DOAJ041496159 (DE-599)DOAJa1991fab92d74b62a64677393da45d7c DE-627 ger DE-627 rakwb eng spa por RA1-1270 Augusto César Ferreira de Moraes verfasserin aut Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review 2009 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier O objetivo do estudo foi revisar a literatura sobre a prevalência da síndrome metabólica e seus componentes em adolescentes (10-19 anos). Realizou-se busca nas bases eletrônicas MEDLINE e SciELO, referências dos artigos encontrados e contato com autores. Apenas artigos originais que utilizaram os critérios da Organização Mundial da Saúde (OMS) ou do National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) foram considerados. Dezesseis estudos preencheram os critérios de inclusão. Destes, oito estudos foram realizados em países de renda baixa ou média, mas nenhum no Brasil. A prevalência de síndrome metabólica entre os estudos que utilizaram o critério da NCEP-ATP III variou de 4,2% a 15,4%. Utilizando-se o critério da OMS, as prevalências foram mais elevadas: 4,5% a 38,7%. Dentre os componentes da síndrome, o triglicéride elevado apresentou maior prevalência, com valores entre 4,9% a 75%, e a glicose elevada apresentou as menores prevalências. Conclui-se que, apesar do baixo número de estudos localizados, a ocorrência da síndrome metabólica entre adolescentes é um problema de saúde com alta prevalência. A prevalência de síndrome metabólica em adolescentes brasileiros é desconhecida.<br<The present study aimed to review the literature on the prevalence of metabolic syndrome and its components in adolescents (10-19 years old). The search was conducted in online databases (MEDLINE and SciELO), references from retrieved articles, and contacts with authors. Only original articles using either the criteria of the World Health Organization (WHO) or the National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP-III) were considered. Sixteen studies met the inclusion criteria. Eight studies were undertaken in low to medium-income countries, but none of them in Brazil. Prevalence of metabolic syndrome in studies using the NCEP-ATP III criteria ranged from 4.2% to 15.4%. Prevalence in studies using the WHO criteria was slightly higher: 4.5% to 38.7%. High triglyceride level was the most frequent component of the metabolic syndrome, with prevalence ranging from 4.9% to 75.0%, while high blood glucose showed the lowest prevalence. In conclusion, although there are few available studies, metabolic syndrome in adolescents is a highly prevalent health issue. The exact prevalence of metabolic syndrome in Brazilian adolescents is unknown. Adolescente Síndrome Metabólica X Obesidade Adolescent Metabolic X Syndrome Obesity Medicine R Public aspects of medicine Camila Sanchez Fulaz verfasserin aut Edna Regina Netto-Oliveira verfasserin aut Felipe Fossati Reichert verfasserin aut In Cadernos de Saúde Pública Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2004 25(2009), 6, Seite 1195-1202 (DE-627)324484798 (DE-600)2027139-6 16784464 nnns volume:25 year:2009 number:6 pages:1195-1202 https://doi.org/10.1590/S0102-311X2009000600002 kostenfrei https://doaj.org/article/a1991fab92d74b62a64677393da45d7c kostenfrei http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2009000600002 kostenfrei https://doaj.org/toc/0102-311X Journal toc kostenfrei https://doaj.org/toc/1678-4464 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2009 6 1195-1202 |
| allfields_unstemmed |
10.1590/S0102-311X2009000600002 doi (DE-627)DOAJ041496159 (DE-599)DOAJa1991fab92d74b62a64677393da45d7c DE-627 ger DE-627 rakwb eng spa por RA1-1270 Augusto César Ferreira de Moraes verfasserin aut Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review 2009 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier O objetivo do estudo foi revisar a literatura sobre a prevalência da síndrome metabólica e seus componentes em adolescentes (10-19 anos). Realizou-se busca nas bases eletrônicas MEDLINE e SciELO, referências dos artigos encontrados e contato com autores. Apenas artigos originais que utilizaram os critérios da Organização Mundial da Saúde (OMS) ou do National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) foram considerados. Dezesseis estudos preencheram os critérios de inclusão. Destes, oito estudos foram realizados em países de renda baixa ou média, mas nenhum no Brasil. A prevalência de síndrome metabólica entre os estudos que utilizaram o critério da NCEP-ATP III variou de 4,2% a 15,4%. Utilizando-se o critério da OMS, as prevalências foram mais elevadas: 4,5% a 38,7%. Dentre os componentes da síndrome, o triglicéride elevado apresentou maior prevalência, com valores entre 4,9% a 75%, e a glicose elevada apresentou as menores prevalências. Conclui-se que, apesar do baixo número de estudos localizados, a ocorrência da síndrome metabólica entre adolescentes é um problema de saúde com alta prevalência. A prevalência de síndrome metabólica em adolescentes brasileiros é desconhecida.<br<The present study aimed to review the literature on the prevalence of metabolic syndrome and its components in adolescents (10-19 years old). The search was conducted in online databases (MEDLINE and SciELO), references from retrieved articles, and contacts with authors. Only original articles using either the criteria of the World Health Organization (WHO) or the National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP-III) were considered. Sixteen studies met the inclusion criteria. Eight studies were undertaken in low to medium-income countries, but none of them in Brazil. Prevalence of metabolic syndrome in studies using the NCEP-ATP III criteria ranged from 4.2% to 15.4%. Prevalence in studies using the WHO criteria was slightly higher: 4.5% to 38.7%. High triglyceride level was the most frequent component of the metabolic syndrome, with prevalence ranging from 4.9% to 75.0%, while high blood glucose showed the lowest prevalence. In conclusion, although there are few available studies, metabolic syndrome in adolescents is a highly prevalent health issue. The exact prevalence of metabolic syndrome in Brazilian adolescents is unknown. Adolescente Síndrome Metabólica X Obesidade Adolescent Metabolic X Syndrome Obesity Medicine R Public aspects of medicine Camila Sanchez Fulaz verfasserin aut Edna Regina Netto-Oliveira verfasserin aut Felipe Fossati Reichert verfasserin aut In Cadernos de Saúde Pública Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2004 25(2009), 6, Seite 1195-1202 (DE-627)324484798 (DE-600)2027139-6 16784464 nnns volume:25 year:2009 number:6 pages:1195-1202 https://doi.org/10.1590/S0102-311X2009000600002 kostenfrei https://doaj.org/article/a1991fab92d74b62a64677393da45d7c kostenfrei http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2009000600002 kostenfrei https://doaj.org/toc/0102-311X Journal toc kostenfrei https://doaj.org/toc/1678-4464 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2009 6 1195-1202 |
| allfieldsGer |
10.1590/S0102-311X2009000600002 doi (DE-627)DOAJ041496159 (DE-599)DOAJa1991fab92d74b62a64677393da45d7c DE-627 ger DE-627 rakwb eng spa por RA1-1270 Augusto César Ferreira de Moraes verfasserin aut Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review 2009 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier O objetivo do estudo foi revisar a literatura sobre a prevalência da síndrome metabólica e seus componentes em adolescentes (10-19 anos). Realizou-se busca nas bases eletrônicas MEDLINE e SciELO, referências dos artigos encontrados e contato com autores. Apenas artigos originais que utilizaram os critérios da Organização Mundial da Saúde (OMS) ou do National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) foram considerados. Dezesseis estudos preencheram os critérios de inclusão. Destes, oito estudos foram realizados em países de renda baixa ou média, mas nenhum no Brasil. A prevalência de síndrome metabólica entre os estudos que utilizaram o critério da NCEP-ATP III variou de 4,2% a 15,4%. Utilizando-se o critério da OMS, as prevalências foram mais elevadas: 4,5% a 38,7%. Dentre os componentes da síndrome, o triglicéride elevado apresentou maior prevalência, com valores entre 4,9% a 75%, e a glicose elevada apresentou as menores prevalências. Conclui-se que, apesar do baixo número de estudos localizados, a ocorrência da síndrome metabólica entre adolescentes é um problema de saúde com alta prevalência. A prevalência de síndrome metabólica em adolescentes brasileiros é desconhecida.<br<The present study aimed to review the literature on the prevalence of metabolic syndrome and its components in adolescents (10-19 years old). The search was conducted in online databases (MEDLINE and SciELO), references from retrieved articles, and contacts with authors. Only original articles using either the criteria of the World Health Organization (WHO) or the National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP-III) were considered. Sixteen studies met the inclusion criteria. Eight studies were undertaken in low to medium-income countries, but none of them in Brazil. Prevalence of metabolic syndrome in studies using the NCEP-ATP III criteria ranged from 4.2% to 15.4%. Prevalence in studies using the WHO criteria was slightly higher: 4.5% to 38.7%. High triglyceride level was the most frequent component of the metabolic syndrome, with prevalence ranging from 4.9% to 75.0%, while high blood glucose showed the lowest prevalence. In conclusion, although there are few available studies, metabolic syndrome in adolescents is a highly prevalent health issue. The exact prevalence of metabolic syndrome in Brazilian adolescents is unknown. Adolescente Síndrome Metabólica X Obesidade Adolescent Metabolic X Syndrome Obesity Medicine R Public aspects of medicine Camila Sanchez Fulaz verfasserin aut Edna Regina Netto-Oliveira verfasserin aut Felipe Fossati Reichert verfasserin aut In Cadernos de Saúde Pública Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2004 25(2009), 6, Seite 1195-1202 (DE-627)324484798 (DE-600)2027139-6 16784464 nnns volume:25 year:2009 number:6 pages:1195-1202 https://doi.org/10.1590/S0102-311X2009000600002 kostenfrei https://doaj.org/article/a1991fab92d74b62a64677393da45d7c kostenfrei http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2009000600002 kostenfrei https://doaj.org/toc/0102-311X Journal toc kostenfrei https://doaj.org/toc/1678-4464 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2009 6 1195-1202 |
| allfieldsSound |
10.1590/S0102-311X2009000600002 doi (DE-627)DOAJ041496159 (DE-599)DOAJa1991fab92d74b62a64677393da45d7c DE-627 ger DE-627 rakwb eng spa por RA1-1270 Augusto César Ferreira de Moraes verfasserin aut Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review 2009 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier O objetivo do estudo foi revisar a literatura sobre a prevalência da síndrome metabólica e seus componentes em adolescentes (10-19 anos). Realizou-se busca nas bases eletrônicas MEDLINE e SciELO, referências dos artigos encontrados e contato com autores. Apenas artigos originais que utilizaram os critérios da Organização Mundial da Saúde (OMS) ou do National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) foram considerados. Dezesseis estudos preencheram os critérios de inclusão. Destes, oito estudos foram realizados em países de renda baixa ou média, mas nenhum no Brasil. A prevalência de síndrome metabólica entre os estudos que utilizaram o critério da NCEP-ATP III variou de 4,2% a 15,4%. Utilizando-se o critério da OMS, as prevalências foram mais elevadas: 4,5% a 38,7%. Dentre os componentes da síndrome, o triglicéride elevado apresentou maior prevalência, com valores entre 4,9% a 75%, e a glicose elevada apresentou as menores prevalências. Conclui-se que, apesar do baixo número de estudos localizados, a ocorrência da síndrome metabólica entre adolescentes é um problema de saúde com alta prevalência. A prevalência de síndrome metabólica em adolescentes brasileiros é desconhecida.<br<The present study aimed to review the literature on the prevalence of metabolic syndrome and its components in adolescents (10-19 years old). The search was conducted in online databases (MEDLINE and SciELO), references from retrieved articles, and contacts with authors. Only original articles using either the criteria of the World Health Organization (WHO) or the National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP-III) were considered. Sixteen studies met the inclusion criteria. Eight studies were undertaken in low to medium-income countries, but none of them in Brazil. Prevalence of metabolic syndrome in studies using the NCEP-ATP III criteria ranged from 4.2% to 15.4%. Prevalence in studies using the WHO criteria was slightly higher: 4.5% to 38.7%. High triglyceride level was the most frequent component of the metabolic syndrome, with prevalence ranging from 4.9% to 75.0%, while high blood glucose showed the lowest prevalence. In conclusion, although there are few available studies, metabolic syndrome in adolescents is a highly prevalent health issue. The exact prevalence of metabolic syndrome in Brazilian adolescents is unknown. Adolescente Síndrome Metabólica X Obesidade Adolescent Metabolic X Syndrome Obesity Medicine R Public aspects of medicine Camila Sanchez Fulaz verfasserin aut Edna Regina Netto-Oliveira verfasserin aut Felipe Fossati Reichert verfasserin aut In Cadernos de Saúde Pública Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2004 25(2009), 6, Seite 1195-1202 (DE-627)324484798 (DE-600)2027139-6 16784464 nnns volume:25 year:2009 number:6 pages:1195-1202 https://doi.org/10.1590/S0102-311X2009000600002 kostenfrei https://doaj.org/article/a1991fab92d74b62a64677393da45d7c kostenfrei http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2009000600002 kostenfrei https://doaj.org/toc/0102-311X Journal toc kostenfrei https://doaj.org/toc/1678-4464 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2009 6 1195-1202 |
| language |
English Spanish Portuguese |
| source |
In Cadernos de Saúde Pública 25(2009), 6, Seite 1195-1202 volume:25 year:2009 number:6 pages:1195-1202 |
| sourceStr |
In Cadernos de Saúde Pública 25(2009), 6, Seite 1195-1202 volume:25 year:2009 number:6 pages:1195-1202 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Adolescente Síndrome Metabólica X Obesidade Adolescent Metabolic X Syndrome Obesity Medicine R Public aspects of medicine |
| isfreeaccess_bool |
true |
| container_title |
Cadernos de Saúde Pública |
| authorswithroles_txt_mv |
Augusto César Ferreira de Moraes @@aut@@ Camila Sanchez Fulaz @@aut@@ Edna Regina Netto-Oliveira @@aut@@ Felipe Fossati Reichert @@aut@@ |
| publishDateDaySort_date |
2009-01-01T00:00:00Z |
| hierarchy_top_id |
324484798 |
| id |
DOAJ041496159 |
| language_de |
englisch spanisch portugiesisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ041496159</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308050535.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2009 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1590/S0102-311X2009000600002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ041496159</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJa1991fab92d74b62a64677393da45d7c</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">spa</subfield><subfield code="a">por</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA1-1270</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Augusto César Ferreira de Moraes</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2009</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">O objetivo do estudo foi revisar a literatura sobre a prevalência da síndrome metabólica e seus componentes em adolescentes (10-19 anos). Realizou-se busca nas bases eletrônicas MEDLINE e SciELO, referências dos artigos encontrados e contato com autores. Apenas artigos originais que utilizaram os critérios da Organização Mundial da Saúde (OMS) ou do National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) foram considerados. Dezesseis estudos preencheram os critérios de inclusão. Destes, oito estudos foram realizados em países de renda baixa ou média, mas nenhum no Brasil. A prevalência de síndrome metabólica entre os estudos que utilizaram o critério da NCEP-ATP III variou de 4,2% a 15,4%. Utilizando-se o critério da OMS, as prevalências foram mais elevadas: 4,5% a 38,7%. Dentre os componentes da síndrome, o triglicéride elevado apresentou maior prevalência, com valores entre 4,9% a 75%, e a glicose elevada apresentou as menores prevalências. Conclui-se que, apesar do baixo número de estudos localizados, a ocorrência da síndrome metabólica entre adolescentes é um problema de saúde com alta prevalência. A prevalência de síndrome metabólica em adolescentes brasileiros é desconhecida.<br<The present study aimed to review the literature on the prevalence of metabolic syndrome and its components in adolescents (10-19 years old). The search was conducted in online databases (MEDLINE and SciELO), references from retrieved articles, and contacts with authors. Only original articles using either the criteria of the World Health Organization (WHO) or the National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP-III) were considered. Sixteen studies met the inclusion criteria. Eight studies were undertaken in low to medium-income countries, but none of them in Brazil. Prevalence of metabolic syndrome in studies using the NCEP-ATP III criteria ranged from 4.2% to 15.4%. Prevalence in studies using the WHO criteria was slightly higher: 4.5% to 38.7%. High triglyceride level was the most frequent component of the metabolic syndrome, with prevalence ranging from 4.9% to 75.0%, while high blood glucose showed the lowest prevalence. In conclusion, although there are few available studies, metabolic syndrome in adolescents is a highly prevalent health issue. The exact prevalence of metabolic syndrome in Brazilian adolescents is unknown.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adolescente</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Síndrome Metabólica X</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Obesidade</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adolescent</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolic X Syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Obesity</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Public aspects of medicine</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Camila Sanchez Fulaz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Edna Regina Netto-Oliveira</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Felipe Fossati Reichert</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Cadernos de Saúde Pública</subfield><subfield code="d">Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2004</subfield><subfield code="g">25(2009), 6, Seite 1195-1202</subfield><subfield code="w">(DE-627)324484798</subfield><subfield code="w">(DE-600)2027139-6</subfield><subfield code="x">16784464</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2009</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:1195-1202</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1590/S0102-311X2009000600002</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/a1991fab92d74b62a64677393da45d7c</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2009000600002</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0102-311X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1678-4464</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2009</subfield><subfield code="e">6</subfield><subfield code="h">1195-1202</subfield></datafield></record></collection>
|
| callnumber-first |
R - Medicine |
| author |
Augusto César Ferreira de Moraes |
| spellingShingle |
Augusto César Ferreira de Moraes misc RA1-1270 misc Adolescente misc Síndrome Metabólica X misc Obesidade misc Adolescent misc Metabolic X Syndrome misc Obesity misc Medicine misc R misc Public aspects of medicine Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review |
| authorStr |
Augusto César Ferreira de Moraes |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)324484798 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
RA1-1270 |
| illustrated |
Not Illustrated |
| issn |
16784464 |
| topic_title |
RA1-1270 Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review Adolescente Síndrome Metabólica X Obesidade Adolescent Metabolic X Syndrome Obesity |
| topic |
misc RA1-1270 misc Adolescente misc Síndrome Metabólica X misc Obesidade misc Adolescent misc Metabolic X Syndrome misc Obesity misc Medicine misc R misc Public aspects of medicine |
| topic_unstemmed |
misc RA1-1270 misc Adolescente misc Síndrome Metabólica X misc Obesidade misc Adolescent misc Metabolic X Syndrome misc Obesity misc Medicine misc R misc Public aspects of medicine |
| topic_browse |
misc RA1-1270 misc Adolescente misc Síndrome Metabólica X misc Obesidade misc Adolescent misc Metabolic X Syndrome misc Obesity misc Medicine misc R misc Public aspects of medicine |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Cadernos de Saúde Pública |
| hierarchy_parent_id |
324484798 |
| hierarchy_top_title |
Cadernos de Saúde Pública |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)324484798 (DE-600)2027139-6 |
| title |
Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review |
| ctrlnum |
(DE-627)DOAJ041496159 (DE-599)DOAJa1991fab92d74b62a64677393da45d7c |
| title_full |
Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review |
| author_sort |
Augusto César Ferreira de Moraes |
| journal |
Cadernos de Saúde Pública |
| journalStr |
Cadernos de Saúde Pública |
| callnumber-first-code |
R |
| lang_code |
eng spa por |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2009 |
| contenttype_str_mv |
txt |
| container_start_page |
1195 |
| author_browse |
Augusto César Ferreira de Moraes Camila Sanchez Fulaz Edna Regina Netto-Oliveira Felipe Fossati Reichert |
| container_volume |
25 |
| class |
RA1-1270 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Augusto César Ferreira de Moraes |
| doi_str_mv |
10.1590/S0102-311X2009000600002 |
| author2-role |
verfasserin |
| title_sort |
prevalência de síndrome metabólica em adolescentes: uma revisão sistemática prevalence of metabolic syndrome in adolescents: a systematic review |
| callnumber |
RA1-1270 |
| title_auth |
Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review |
| abstract |
O objetivo do estudo foi revisar a literatura sobre a prevalência da síndrome metabólica e seus componentes em adolescentes (10-19 anos). Realizou-se busca nas bases eletrônicas MEDLINE e SciELO, referências dos artigos encontrados e contato com autores. Apenas artigos originais que utilizaram os critérios da Organização Mundial da Saúde (OMS) ou do National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) foram considerados. Dezesseis estudos preencheram os critérios de inclusão. Destes, oito estudos foram realizados em países de renda baixa ou média, mas nenhum no Brasil. A prevalência de síndrome metabólica entre os estudos que utilizaram o critério da NCEP-ATP III variou de 4,2% a 15,4%. Utilizando-se o critério da OMS, as prevalências foram mais elevadas: 4,5% a 38,7%. Dentre os componentes da síndrome, o triglicéride elevado apresentou maior prevalência, com valores entre 4,9% a 75%, e a glicose elevada apresentou as menores prevalências. Conclui-se que, apesar do baixo número de estudos localizados, a ocorrência da síndrome metabólica entre adolescentes é um problema de saúde com alta prevalência. A prevalência de síndrome metabólica em adolescentes brasileiros é desconhecida.<br<The present study aimed to review the literature on the prevalence of metabolic syndrome and its components in adolescents (10-19 years old). The search was conducted in online databases (MEDLINE and SciELO), references from retrieved articles, and contacts with authors. Only original articles using either the criteria of the World Health Organization (WHO) or the National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP-III) were considered. Sixteen studies met the inclusion criteria. Eight studies were undertaken in low to medium-income countries, but none of them in Brazil. Prevalence of metabolic syndrome in studies using the NCEP-ATP III criteria ranged from 4.2% to 15.4%. Prevalence in studies using the WHO criteria was slightly higher: 4.5% to 38.7%. High triglyceride level was the most frequent component of the metabolic syndrome, with prevalence ranging from 4.9% to 75.0%, while high blood glucose showed the lowest prevalence. In conclusion, although there are few available studies, metabolic syndrome in adolescents is a highly prevalent health issue. The exact prevalence of metabolic syndrome in Brazilian adolescents is unknown. |
| abstractGer |
O objetivo do estudo foi revisar a literatura sobre a prevalência da síndrome metabólica e seus componentes em adolescentes (10-19 anos). Realizou-se busca nas bases eletrônicas MEDLINE e SciELO, referências dos artigos encontrados e contato com autores. Apenas artigos originais que utilizaram os critérios da Organização Mundial da Saúde (OMS) ou do National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) foram considerados. Dezesseis estudos preencheram os critérios de inclusão. Destes, oito estudos foram realizados em países de renda baixa ou média, mas nenhum no Brasil. A prevalência de síndrome metabólica entre os estudos que utilizaram o critério da NCEP-ATP III variou de 4,2% a 15,4%. Utilizando-se o critério da OMS, as prevalências foram mais elevadas: 4,5% a 38,7%. Dentre os componentes da síndrome, o triglicéride elevado apresentou maior prevalência, com valores entre 4,9% a 75%, e a glicose elevada apresentou as menores prevalências. Conclui-se que, apesar do baixo número de estudos localizados, a ocorrência da síndrome metabólica entre adolescentes é um problema de saúde com alta prevalência. A prevalência de síndrome metabólica em adolescentes brasileiros é desconhecida.<br<The present study aimed to review the literature on the prevalence of metabolic syndrome and its components in adolescents (10-19 years old). The search was conducted in online databases (MEDLINE and SciELO), references from retrieved articles, and contacts with authors. Only original articles using either the criteria of the World Health Organization (WHO) or the National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP-III) were considered. Sixteen studies met the inclusion criteria. Eight studies were undertaken in low to medium-income countries, but none of them in Brazil. Prevalence of metabolic syndrome in studies using the NCEP-ATP III criteria ranged from 4.2% to 15.4%. Prevalence in studies using the WHO criteria was slightly higher: 4.5% to 38.7%. High triglyceride level was the most frequent component of the metabolic syndrome, with prevalence ranging from 4.9% to 75.0%, while high blood glucose showed the lowest prevalence. In conclusion, although there are few available studies, metabolic syndrome in adolescents is a highly prevalent health issue. The exact prevalence of metabolic syndrome in Brazilian adolescents is unknown. |
| abstract_unstemmed |
O objetivo do estudo foi revisar a literatura sobre a prevalência da síndrome metabólica e seus componentes em adolescentes (10-19 anos). Realizou-se busca nas bases eletrônicas MEDLINE e SciELO, referências dos artigos encontrados e contato com autores. Apenas artigos originais que utilizaram os critérios da Organização Mundial da Saúde (OMS) ou do National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) foram considerados. Dezesseis estudos preencheram os critérios de inclusão. Destes, oito estudos foram realizados em países de renda baixa ou média, mas nenhum no Brasil. A prevalência de síndrome metabólica entre os estudos que utilizaram o critério da NCEP-ATP III variou de 4,2% a 15,4%. Utilizando-se o critério da OMS, as prevalências foram mais elevadas: 4,5% a 38,7%. Dentre os componentes da síndrome, o triglicéride elevado apresentou maior prevalência, com valores entre 4,9% a 75%, e a glicose elevada apresentou as menores prevalências. Conclui-se que, apesar do baixo número de estudos localizados, a ocorrência da síndrome metabólica entre adolescentes é um problema de saúde com alta prevalência. A prevalência de síndrome metabólica em adolescentes brasileiros é desconhecida.<br<The present study aimed to review the literature on the prevalence of metabolic syndrome and its components in adolescents (10-19 years old). The search was conducted in online databases (MEDLINE and SciELO), references from retrieved articles, and contacts with authors. Only original articles using either the criteria of the World Health Organization (WHO) or the National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP-III) were considered. Sixteen studies met the inclusion criteria. Eight studies were undertaken in low to medium-income countries, but none of them in Brazil. Prevalence of metabolic syndrome in studies using the NCEP-ATP III criteria ranged from 4.2% to 15.4%. Prevalence in studies using the WHO criteria was slightly higher: 4.5% to 38.7%. High triglyceride level was the most frequent component of the metabolic syndrome, with prevalence ranging from 4.9% to 75.0%, while high blood glucose showed the lowest prevalence. In conclusion, although there are few available studies, metabolic syndrome in adolescents is a highly prevalent health issue. The exact prevalence of metabolic syndrome in Brazilian adolescents is unknown. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
| container_issue |
6 |
| title_short |
Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review |
| url |
https://doi.org/10.1590/S0102-311X2009000600002 https://doaj.org/article/a1991fab92d74b62a64677393da45d7c http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2009000600002 https://doaj.org/toc/0102-311X https://doaj.org/toc/1678-4464 |
| remote_bool |
true |
| author2 |
Camila Sanchez Fulaz Edna Regina Netto-Oliveira Felipe Fossati Reichert |
| author2Str |
Camila Sanchez Fulaz Edna Regina Netto-Oliveira Felipe Fossati Reichert |
| ppnlink |
324484798 |
| callnumber-subject |
RA - Public Medicine |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.1590/S0102-311X2009000600002 |
| callnumber-a |
RA1-1270 |
| up_date |
2024-07-03T20:33:21.015Z |
| _version_ |
1803591405817298944 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ041496159</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308050535.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2009 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1590/S0102-311X2009000600002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ041496159</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJa1991fab92d74b62a64677393da45d7c</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">spa</subfield><subfield code="a">por</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA1-1270</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Augusto César Ferreira de Moraes</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática Prevalence of metabolic syndrome in adolescents: a systematic review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2009</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">O objetivo do estudo foi revisar a literatura sobre a prevalência da síndrome metabólica e seus componentes em adolescentes (10-19 anos). Realizou-se busca nas bases eletrônicas MEDLINE e SciELO, referências dos artigos encontrados e contato com autores. Apenas artigos originais que utilizaram os critérios da Organização Mundial da Saúde (OMS) ou do National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) foram considerados. Dezesseis estudos preencheram os critérios de inclusão. Destes, oito estudos foram realizados em países de renda baixa ou média, mas nenhum no Brasil. A prevalência de síndrome metabólica entre os estudos que utilizaram o critério da NCEP-ATP III variou de 4,2% a 15,4%. Utilizando-se o critério da OMS, as prevalências foram mais elevadas: 4,5% a 38,7%. Dentre os componentes da síndrome, o triglicéride elevado apresentou maior prevalência, com valores entre 4,9% a 75%, e a glicose elevada apresentou as menores prevalências. Conclui-se que, apesar do baixo número de estudos localizados, a ocorrência da síndrome metabólica entre adolescentes é um problema de saúde com alta prevalência. A prevalência de síndrome metabólica em adolescentes brasileiros é desconhecida.<br<The present study aimed to review the literature on the prevalence of metabolic syndrome and its components in adolescents (10-19 years old). The search was conducted in online databases (MEDLINE and SciELO), references from retrieved articles, and contacts with authors. Only original articles using either the criteria of the World Health Organization (WHO) or the National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP-III) were considered. Sixteen studies met the inclusion criteria. Eight studies were undertaken in low to medium-income countries, but none of them in Brazil. Prevalence of metabolic syndrome in studies using the NCEP-ATP III criteria ranged from 4.2% to 15.4%. Prevalence in studies using the WHO criteria was slightly higher: 4.5% to 38.7%. High triglyceride level was the most frequent component of the metabolic syndrome, with prevalence ranging from 4.9% to 75.0%, while high blood glucose showed the lowest prevalence. In conclusion, although there are few available studies, metabolic syndrome in adolescents is a highly prevalent health issue. The exact prevalence of metabolic syndrome in Brazilian adolescents is unknown.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adolescente</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Síndrome Metabólica X</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Obesidade</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adolescent</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolic X Syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Obesity</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Public aspects of medicine</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Camila Sanchez Fulaz</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Edna Regina Netto-Oliveira</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Felipe Fossati Reichert</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Cadernos de Saúde Pública</subfield><subfield code="d">Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2004</subfield><subfield code="g">25(2009), 6, Seite 1195-1202</subfield><subfield code="w">(DE-627)324484798</subfield><subfield code="w">(DE-600)2027139-6</subfield><subfield code="x">16784464</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2009</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:1195-1202</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1590/S0102-311X2009000600002</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/a1991fab92d74b62a64677393da45d7c</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2009000600002</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0102-311X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1678-4464</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2009</subfield><subfield code="e">6</subfield><subfield code="h">1195-1202</subfield></datafield></record></collection>
|
| score |
7.402793 |